PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING OF CREATININE-DRUG INTERACTION IN CHRONIC KIDNEY DISEASE POPULATION.

被引：0
|
作者：
Takita, H. [1 ,2 ]
Scotcher, D. [1 ]
Chinnadurai, R. [3 ]
Kalra, P. [3 ]
Galetin, A. [1 ]
机构：
[1] Univ Manchester, Manchester, Lancs, England
[2] Asahi Kasei Pharma, Shizuoka, Japan
[3] Salford Royal NHS Fdn Trust, Salford, Lancs, England
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-130
引用
收藏
页码：S113 / S114
页数：2
相关论文
共 50 条
  • [31] Physiologically-based pharmacokinetic modeling of ziprasidone in pregnant women
    Biesdorf, Carla
    Martins, Frederico
    Diniz, Andrea
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S12 - S13
  • [32] A Comprehensive Framework for Physiologically-Based Pharmacokinetic Modeling in Matlab
    Stader, Felix
    Penny, Melissa A.
    Siccardi, Marco
    Marzolini, Catia
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (07): : 444 - 459
  • [33] Physiologically-Based Pharmacokinetic Modeling: Parameter Estimation for Cyclosporin A
    Lueshen, Eric
    Hall, Cierra
    Mosat, Andrej
    Linninger, Andreas
    21ST EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, 2011, 29 : 1543 - 1547
  • [34] Chronic kidney disease and physiologically based pharmacokinetic modeling: a critical review of existing models
    Zamir, Ammara
    Alqahtani, Faleh
    Rasool, Muhammad Fawad
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (1-2) : 95 - 105
  • [35] A physiologically-based pharmacokinetic/pharmacodynamic modeling approach for drug-drug-gene interaction evaluation of S-warfarin with fluconazole
    Geng, Kuo
    Shen, Chaozhuang
    Wang, Xiaohu
    Wang, Xingwen
    Shao, Wenxin
    Wang, Wenhui
    Chen, Tao
    Sun, Hua
    Xie, Haitang
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (05): : 853 - 869
  • [36] PREDICTING DRUG-DRUG INTERACTION POTENTIAL BETWEEN VALPROIC ACID AND VIXOTRIGINE USING PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING.
    Zhao, Y.
    Rooney, M.
    Naik, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S48 - S48
  • [37] Morphomics-informed population pharmacokinetic and physiologically-based pharmacokinetic modeling to optimize cefazolin surgical prophylaxis
    Liu, Shuhan
    Matvekas, Aleksas
    Naimi, Tamara
    Ghanem, Aws
    Li, Ruiting
    Rajanayake, Krishani
    Derstine, Brian
    Ross, Brian
    Sullivan, June
    Yun, Hyun Gi
    Regenbogen, Scott
    Byrn, John
    Su, Grace
    Wang, Stewart
    Pai, Manjunath P.
    PHARMACOTHERAPY, 2024, 44 (01): : 77 - 86
  • [38] Physiologically-based pharmacokinetic modeling of target-mediated drug disposition of bortezomib in mice
    Zhang, Li
    Mager, Donald E.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 (05) : 541 - 552
  • [39] Physiologically-based pharmacokinetic modeling of target-mediated drug disposition of bortezomib in mice
    Li Zhang
    Donald E. Mager
    Journal of Pharmacokinetics and Pharmacodynamics, 2015, 42 : 541 - 552
  • [40] A best practice framework for applying physiologically-based pharmacokinetic modeling to pediatric drug development
    Johnson, Trevor N.
    Small, Ben G.
    Berglund, Eva Gil
    Rowland Yeo, Karen
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (09): : 967 - 972
12345